Results 71 to 80 of about 114,186,541 (190)

Pseudotype-based neutralization assays for influenza: a systematic analysis [PDF]

open access: yes, 2015
The use of vaccination against the influenza virus remains the most effective method of mitigating the significant morbidity and mortality caused by this virus.
Ferrara, Francesca   +11 more
core   +1 more source

TEAM: A time‐enhanced attention‐based model for virus mutation prediction

open access: yesQuantitative Biology, Volume 14, Issue 4, December 2026.
Abstract The evolution of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) during the coronavirus disease 2019 (COVID‐19) pandemic highlights the critical need for predicting virus mutations in order to stay ahead of infectious diseases. Here, we present the time‐enhanced attention‐based model (TEAM), which combines phylogenetic sampling ...
Jie Ji, Jie Hu, Tianwei Yu, Xiaodan Fan
wiley   +1 more source

Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections. [PDF]

open access: yesEmerg Microbes Infect, 2019
Haemagglutination inhibition (HAI) antibody titres are a correlate of protection for influenza virus infection, but several studies have also demonstrated the protective role of anti-neuraminidase (anti-NA) antibodies. However, there is limited data on anti-NA antibody responses in naturally occurring human influenza.
Karunarathna HMTK   +5 more
europepmc   +5 more sources

Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico [PDF]

open access: yes, 2009
Background: An accurate estimate of the total number of cases and severity of illness of an emerging infectious disease is required both to define the burden of the epidemic and to determine the severity of disease. When a novel pathogen first appears,
Dowell, Scott F.   +50 more
core   +1 more source

Antiviral Resistance Associated With Multiple Mutations Occurring in Seasonal Influenza A(H3N2) Virus in a Patient Treated With Oseltamivir

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Our case highlights the importance of early diagnosis in respiratory illness and timely detection of drug resistance so that antiviral treatment can be initiated and modified, particularly for high‐risk groups. Vaccination and early, carefully dosed antiviral treatment are key to mitigating severe influenza cases, especially in ...
Saira Hussain   +9 more
wiley   +1 more source

The Effect of Risk Perception on the 2009 H1N1 Pandemic Influenza Dynamics [PDF]

open access: yes, 2011
Background: The 2009 H1N1 pandemic influenza dynamics in Italy was characterized by a notable pattern: as it emerged from the analysis of influenza-like illness data, after an initial period (September–mid-October 2009) characterized by a slow ...
Poletti Piero   +10 more
core   +1 more source

Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies

open access: yesPLoS ONE, 2014
Contexte Les données des études de cohorte planifiées prospectivement sur le risque de résultats cliniques majeurs et les facteurs pronostiques pour les patients atteints du virus de la grippe A(H1N1)pdm09 sont limitées. En 2009, afin d'évaluer les résultats et d'évaluer les facteurs de risque de progression de la maladie, deux études de cohorte ont ...
Lynfield, Ruth   +24 more
openaire   +9 more sources

Causes and Contributing Factors of In‐Hospital and Post‐Discharge Mortality Among Patients With Severe Acute Respiratory Infection in Low‐ and Middle‐Income Countries: A Scoping Review

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Severe acute respiratory infections (SARI) remain a major cause of global morbidity and mortality, with a disproportionate burden in low‐ and middle‐income countries (LMICs). Although in‐hospital mortality is frequently reported, deaths occurring after hospital discharge remain poorly documented.
Md Ariful Islam   +7 more
wiley   +1 more source

Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017–2020

open access: yesScientific Reports, 2021
We monitored the circulating strains and genetic variation among seasonal influenza A and B viruses in Thailand between July 2017 and March 2020. The hemagglutinin gene was amplified and sequenced.
Nungruthai Suntronwong   +6 more
doaj   +1 more source

Molecular genetic factors of pathogenicity of influenza A virus (H1N1) pdm09

open access: yesEpidemiology and Infectious Diseases, 2014
Unlike influenza epidemics which affect the population almost yearly, pandemics occur much less frequently, but have more severe medical and social consequences. The investigation of the nature of the course of all modern epidemics and pandemics are acquiring the particular rationale.
V. V Tsvetkov   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy